Denmark drops Johnson and Johnson COVID-19 vaccine
A statement read: "The Danish Health Authority has concluded that the benefits of using the COVID-19 vaccine from Johnson & Johnson do not outweigh the risk of causing the possible adverse effect, VITT, in those who receive the vaccine. Therefore, the Danish Health Authority will continue the Danish mass vaccination programme against COVID-19 without the COVID-19 vaccine from Johnson & Johnson."
The decision was not an easy one to make, it stressed, particularly after also having dropped AstraZeneca's vaccine.
"Taking the present situation in Denmark into account, what we are currently losing in our effort to prevent severe illness from COVID-19 cannot outweigh the risk of causing possible side effects in the form of severe blood clots in those we vaccinate," the statement went on.
"The remaining target groups will experience a delay of about one week, as we will be getting large amounts of other vaccines," it went on. ■